JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $359,000 | -43.9% | 7,860 | -44.9% | 0.45% | +423.3% |
| Q3 2017 | $640,000 | +65.4% | 14,261 | +10.1% | 0.09% | +48.3% |
| Q2 2017 | $387,000 | +11.5% | 12,957 | -17.2% | 0.06% | -6.5% |
| Q1 2017 | $347,000 | +30.0% | 15,654 | +10.6% | 0.06% | -22.5% |
| Q4 2016 | $267,000 | +47.5% | 14,153 | +135.2% | 0.08% | -9.1% |
| Q3 2016 | $181,000 | -21.6% | 6,017 | 0.0% | 0.09% | -48.5% |
| Q2 2016 | $231,000 | +13.2% | 6,017 | +12.4% | 0.17% | -39.1% |
| Q1 2016 | $204,000 | – | 5,353 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $85,211,000 | 94.86% |
| Crestline Management, LP | 7,631,631 | $348,841,000 | 35.74% |
| Omega Fund Management, LLC | 753,564 | $34,445,000 | 24.90% |
| DDD Partners, LLC | 191,458 | $8,752,000 | 3.40% |
| SIB LLC | 100,000 | $4,571,000 | 3.28% |
| PECONIC PARTNERS LLC | 433,587 | $19,819,000 | 2.85% |
| Cormorant Asset Management, LP | 550,000 | $25,141,000 | 2.63% |
| ARK Investment Management | 682,495 | $31,197,000 | 2.48% |
| BB BIOTECH AG | 1,925,000 | $87,992,000 | 2.48% |
| Clarius Group, LLC | 120,988 | $5,530,000 | 2.47% |